A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia : Is immunosuppression a risk factor for SARS-COV2 infection?
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2020 |
|---|---|
| Erschienen: |
2020 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:145 |
|---|---|
| Enthalten in: |
Lung cancer (Amsterdam, Netherlands) - 145(2020) vom: 07. Juli, Seite 213-215 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Sereno, María [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 18.06.2020 Date Revised 04.12.2021 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.lungcan.2020.04.029 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM309726247 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM309726247 | ||
| 003 | DE-627 | ||
| 005 | 20231225134541.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2020 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.lungcan.2020.04.029 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1032.xml |
| 035 | |a (DE-627)NLM309726247 | ||
| 035 | |a (NLM)32389426 | ||
| 035 | |a (PII)S0169-5002(20)30399-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Sereno, María |e verfasserin |4 aut | |
| 245 | 1 | 2 | |a A favorable outcome of pneumonia COVID 19 in an advanced lung cancer patient with severe neutropenia |b Is immunosuppression a risk factor for SARS-COV2 infection? |
| 264 | 1 | |c 2020 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 18.06.2020 | ||
| 500 | |a Date Revised 04.12.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Case Reports | |
| 650 | 4 | |a Letter | |
| 650 | 7 | |a Nivolumab |2 NLM | |
| 650 | 7 | |a 31YO63LBSN |2 NLM | |
| 650 | 7 | |a Oxygen |2 NLM | |
| 650 | 7 | |a S88TT14065 |2 NLM | |
| 700 | 1 | |a Gutiérrez-Gutiérrez, Gerardo |e verfasserin |4 aut | |
| 700 | 1 | |a Sandoval, Carmen |e verfasserin |4 aut | |
| 700 | 1 | |a Falagan, Sandra |e verfasserin |4 aut | |
| 700 | 1 | |a Jimenez-Gordo, Ana María |e verfasserin |4 aut | |
| 700 | 1 | |a Merino, María |e verfasserin |4 aut | |
| 700 | 1 | |a López-Menchaca, Ramiro |e verfasserin |4 aut | |
| 700 | 1 | |a Martínez-Martin, Patricia |e verfasserin |4 aut | |
| 700 | 1 | |a Roa, Silvia |e verfasserin |4 aut | |
| 700 | 1 | |a Casado, Enrique |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Lung cancer (Amsterdam, Netherlands) |d 1994 |g 145(2020) vom: 07. Juli, Seite 213-215 |w (DE-627)NLM074973657 |x 1872-8332 |7 nnns |
| 773 | 1 | 8 | |g volume:145 |g year:2020 |g day:07 |g month:07 |g pages:213-215 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.lungcan.2020.04.029 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 145 |j 2020 |b 07 |c 07 |h 213-215 | ||